These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Human stem cells as a model for cardiac differentiation and disease. Beqqali A; van Eldik W; Mummery C; Passier R Cell Mol Life Sci; 2009 Mar; 66(5):800-13. PubMed ID: 19151924 [TBL] [Abstract][Full Text] [Related]
23. Embryonic stem cell markers expression in cancers. Schoenhals M; Kassambara A; De Vos J; Hose D; Moreaux J; Klein B Biochem Biophys Res Commun; 2009 May; 383(2):157-62. PubMed ID: 19268426 [TBL] [Abstract][Full Text] [Related]
24. Oct4-induced pluripotency in adult neural stem cells. Kim JB; Sebastiano V; Wu G; Araúzo-Bravo MJ; Sasse P; Gentile L; Ko K; Ruau D; Ehrich M; van den Boom D; Meyer J; Hübner K; Bernemann C; Ortmeier C; Zenke M; Fleischmann BK; Zaehres H; Schöler HR Cell; 2009 Feb; 136(3):411-9. PubMed ID: 19203577 [TBL] [Abstract][Full Text] [Related]
25. Harnessing stem cells and dendritic cells for novel therapies. Markowicz S Acta Pol Pharm; 2008; 65(6):625-32. PubMed ID: 19172843 [TBL] [Abstract][Full Text] [Related]
26. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973 [TBL] [Abstract][Full Text] [Related]
27. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells. Amoh Y; Kanoh M; Niiyama S; Hamada Y; Kawahara K; Sato Y; Hoffman RM; Katsuoka K J Cell Biochem; 2009 Aug; 107(5):1016-20. PubMed ID: 19507228 [TBL] [Abstract][Full Text] [Related]
28. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Aasen T; Raya A; Barrero MJ; Garreta E; Consiglio A; Gonzalez F; Vassena R; Bilić J; Pekarik V; Tiscornia G; Edel M; Boué S; Izpisúa Belmonte JC Nat Biotechnol; 2008 Nov; 26(11):1276-84. PubMed ID: 18931654 [TBL] [Abstract][Full Text] [Related]
29. Induced human pluripotent stem cells: promises and open questions. Rolletschek A; Wobus AM Biol Chem; 2009 Sep; 390(9):845-9. PubMed ID: 19558327 [TBL] [Abstract][Full Text] [Related]
30. Regenerative medicine: transdifferentiation in vivo. Fu L; Zhu X; Yi F; Liu GH; Izpisua Belmonte JC Cell Res; 2014 Feb; 24(2):141-2. PubMed ID: 24343579 [TBL] [Abstract][Full Text] [Related]
31. Medicine. A history lesson for stem cells. Wilson JM Science; 2009 May; 324(5928):727-8. PubMed ID: 19423804 [No Abstract] [Full Text] [Related]
32. Editorial (hot topic:human pluripotent stem cells in regenerative and personalized medicine). Dittmar T; Rossbach M Curr Mol Med; 2013 Jun; 13(5):691-4. PubMed ID: 23642052 [No Abstract] [Full Text] [Related]
33. Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications. Andrews PW; Ben-David U; Benvenisty N; Coffey P; Eggan K; Knowles BB; Nagy A; Pera M; Reubinoff B; Rugg-Gunn PJ; Stacey GN Stem Cell Reports; 2017 Jul; 9(1):1-4. PubMed ID: 28700896 [TBL] [Abstract][Full Text] [Related]
34. The potential of pluripotent cells in vitreoretinal diseases. Spaide RF Retina; 2008 Oct; 28(8):1031-4. PubMed ID: 18664939 [No Abstract] [Full Text] [Related]